We improved our image dramatically. We hired fo
Post# of 148248
(Total Views: 792)
Posted On: 12/14/2021 2:48:04 PM
We improved our image dramatically.
We hired former REGN, GSK, Pfizer, and Roche employees and expanding.
We have a plan for 8 and possibly 9 big tasks in 2022. The one not listed is Brazil Severe which is currently paused to focus on Brazil Critical 50-51 patients.
Our CRO believes we will have enough power for statistical significance based on our new primary endpoint.
CytoDyn had 3 FDA Division teams help write the Long Hauler protocol which the team is submitting soon.
If our Nash 700Mg are just as good or better than 350Mg, it makes a bigger possibility in working with big pharma for Nash because it’s an unmet medical need.
Since our drug also helped brain metastasis, we will be filing a BTD when we hear back from the FDA.
Since we helped other indications AT THE SAME TIME as helping our target indication, it’s indicative that we will help HIV patients with NASH. Since, NASH is found in a higher percentage in HIV patients.
This would make us be the standard regiment for all HIV patients.
We definitely seem to want to expand globally, let’s go Brendan Rae!
Top Line 700Mg Nash results before Christmas!
BTD for mTNBC before or on January 5th.
We hired former REGN, GSK, Pfizer, and Roche employees and expanding.
We have a plan for 8 and possibly 9 big tasks in 2022. The one not listed is Brazil Severe which is currently paused to focus on Brazil Critical 50-51 patients.
Our CRO believes we will have enough power for statistical significance based on our new primary endpoint.
CytoDyn had 3 FDA Division teams help write the Long Hauler protocol which the team is submitting soon.
If our Nash 700Mg are just as good or better than 350Mg, it makes a bigger possibility in working with big pharma for Nash because it’s an unmet medical need.
Since our drug also helped brain metastasis, we will be filing a BTD when we hear back from the FDA.
Since we helped other indications AT THE SAME TIME as helping our target indication, it’s indicative that we will help HIV patients with NASH. Since, NASH is found in a higher percentage in HIV patients.
This would make us be the standard regiment for all HIV patients.
We definitely seem to want to expand globally, let’s go Brendan Rae!
Top Line 700Mg Nash results before Christmas!
BTD for mTNBC before or on January 5th.
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼